Satellos Bioscience MSLE
NASDAQ MSLE
$6.84 -0.16 (-2.29%)
As of: Oct 21, 2026 · 10:53 AM EDT

Satellos Bioscience (MSLE) EBT (2025 - 2026)

Updated

Satellos Bioscience (MSLE) reported EBT of -$11.67 million for the quarter ended Jun 30, 2026, compared with -$5.58 million a year earlier.

Analysis

Satellos Bioscience (MSLE) EBT (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Satellos Bioscience's EBT came in at -$51.69 million; for the year ended Dec 31, 2025, it was -$24.7 million.

  • By year, EBT came in at -$20.63 million in the year ended Dec 31, 2024.
  • Five-year quarterly EBT spans a low of -$24.7 million in the quarter ended Dec 31, 2025 and a high of $6.08 million in the quarter ended Mar 31, 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,134.50 Bn 1,103.09 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 6.75 Bn
3 AbbVie 500.82 Bn 473.93 Bn 12.70 Bn 4.28 Bn
4 Merck 367.31 Bn 321.69 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 297.77 Bn 261.76 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 261.35 Bn 235.04 Bn 12.86 Bn 2.80 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 190.59 Bn 164.79 Bn 6.22 Bn -10.25 Bn
9 Pfizer 169.39 Bn 116.04 Bn 10.94 Bn -653.00 Mn
10 Satellos Bioscience 99.84 Mn -108.30 Mn - -11.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.67 Mn
Mar 31, 2026 -9.74 Mn
Jun 30, 2025 -5.58 Mn
Mar 31, 2025 6.08 Mn
API Access

Satellos Bioscience EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=MSLE&period=max&api_key=YOUR_API_KEY